Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis.
暂无分享,去创建一个
Yusuke Nakamura | Tatsuhiko Tsunoda | Akira Togashi | Yoko Harima | Yusuke Nakamura | T. Tsunoda | T. Katagiri | Y. Harima | Toyomasa Katagiri | S. Sawada | Satoshi Sawada | Kenichi Horikoshi | Masahiro Imamura | Mitsuharu Sougawa | M. Sougawa | M. Imamura | K. Horikoshi | Akira Togashi | Kenichi Horikoshi
[1] S. Zucoloto,et al. The relationship between p63 and p53 expression in normal and neoplastic breast tissue. , 2009, Archives of pathology & laboratory medicine.
[2] T. Wheeler,et al. Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder. , 2003, Urology.
[3] S. Jalkanen,et al. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. , 2003, Cancer research.
[4] S. Wagner,et al. CD44 variant isoform v10 is expressed on tumor‐infiltrating lymphocytes and mediates hyaluronan‐independent heterotypic cell–cell adhesion to melanoma cells , 2003, Experimental dermatology.
[5] H. Höfler,et al. Invasion factors uPA/PAI-1 and HER2 status provide independent and complementary information on patient outcome in node-negative breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] P. Trempat,et al. Isolation of differentially expressed genes in NPM‐ALK‐positive anaplastic large cell lymphoma , 2002, British journal of haematology.
[7] K. Yasumoto,et al. CD44 stimulation down-regulates Fas expression and Fas-mediated apoptosis of lung cancer cells. , 2001, International immunology.
[8] A. Harris,et al. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] T. Takagi,et al. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. , 2001, Cancer research.
[10] W. Sly,et al. Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. , 2001, The American journal of pathology.
[11] Yao Wang. The role and regulation of urokinase‐type plasminogen activator receptor gene expression in cancer invasion and metastasis , 2001, Medicinal research reviews.
[12] S Sawada,et al. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. , 2001, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[13] P H Watson,et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. , 2000, Cancer research.
[14] A. Yang,et al. p63 and p73: p53 mimics, menaces and more , 2000, Nature Reviews Molecular Cell Biology.
[15] T Tanaka,et al. Identification by cDNA microarray of genes involved in ovarian carcinogenesis. , 2000, Cancer research.
[16] S. Post,et al. Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection , 2000, International journal of pancreatology : official journal of the International Association of Pancreatology.
[17] S. Nagata,et al. Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alpha-induced cell death in fibroblasts. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[18] A. Hart,et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial , 2000, The Lancet.
[19] A. Krüger,et al. The urokinase plasminogen activator system as a novel target for tumour therapy , 2000 .
[20] Y. Harima,et al. Loss of heterozygosity on chromosome 6p21.2 as a potential marker for recurrence after radiotherapy of human cervical cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[21] P. Andreasen,et al. The plasminogen activation system in tumor growth, invasion, and metastasis , 2000, Cellular and Molecular Life Sciences CMLS.
[22] S. Orrenius,et al. Thermotolerance and cell death are distinct cellular responses to stress: dependence on heat shock proteins , 1999, FEBS letters.
[23] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[24] Z. Tulassay,et al. The role of cysteine and serine proteases in colorectal carcinoma , 1999, Cancer.
[25] S. Roberts,et al. Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity , 1999, British Journal of Cancer.
[26] H. Vogel,et al. p63 is a p53 homologue required for limb and epidermal morphogenesis , 1999, Nature.
[27] B N Bundy,et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. , 1999, The New England journal of medicine.
[28] A. Harris,et al. Angiogenesis vs. response after combined chemoradiotherapy of squamous cell head and neck cancer , 1999, International journal of cancer.
[29] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[30] F. Bussolino,et al. Angiogenesis: prognostic significance in laryngeal cancer. , 1998, Anticancer research.
[31] J. Kos,et al. Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). , 1998, Oncology reports.
[32] M. Wei,et al. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[33] A. Fyles,et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[34] G N Shah,et al. Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. Díaz,et al. Dimerization Properties of Human BAD , 1997, The Journal of Biological Chemistry.
[36] Warren S. Alexander,et al. A family of cytokine-inducible inhibitors of signalling , 1997, Nature.
[37] S. Akira,et al. Structure and function of a new STAT-induced STAT inhibitor , 1997, Nature.
[38] R. Kettmann,et al. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. , 1996, Genomics.
[39] P. Dettmar,et al. Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[40] P. Sparén,et al. Strategies for global control of cervical cancer , 1995, International journal of cancer.
[41] Bonnie F. Sloane,et al. Cathepsin B and its endogenous inhibitors: the role in tumor malignancy , 1990, Cancer and Metastasis Reviews.
[42] Bonnie F. Sloane. Cathepsin B and cystatins: evidence for a role in cancer progression. , 1990, Seminars in cancer biology.
[43] R. Gatenby,et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. , 1988, International journal of radiation oncology, biology, physics.
[44] I. Tannock,et al. Response of Chinese hamster ovary cells to anticancer drugs under aerobic and hypoxic conditions. , 1981, British Journal of Cancer.
[45] M. Hattori,et al. Expression of CD44 in primary lung carcinomas using histological and cytological analyses. , 2003, Anticancer Research.
[46] Yusuke Nakamura,et al. Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. , 2002, Neoplasia.
[47] A. Russo,et al. Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[48] Takeo Ohnishi,et al. Bax and Bcl‐2 protein expression following radiation therapy versus radiation plus thermoradiotherapy in stage IIIB cervical carcinoma , 2000, Cancer.
[49] A. Takahashi,et al. Brief communication: heat-induced accumulation of p53 and hsp72 is suppressed in lung fibroblasts from the SCID mouse. , 2000, International journal of radiation biology.
[50] M. Jackson,et al. Gene expression profiles of laser-captured adjacent neuronal subtypes , 1999, Nature Medicine.
[51] Ronit Vogt Sionov,et al. CD44: structure, function, and association with the malignant process. , 1997, Advances in cancer research.
[52] Bonnie F. Sloane,et al. Cathepsin B: multiple enzyme forms from a single gene and their relation to cancer. , 1996, Enzyme & protein.
[53] H. Rochefort,et al. Cathepsin D in breast cancer: a tissue marker associated with metastasis. , 1992, European journal of cancer.
[54] B. Turyna,et al. [Cysteine proteinases and their endogenous inhibitors]. , 1988, Postepy biochemii.